Targeting key proximal drivers of type 2 inflammation in disease
The DOI matches its Crossref record; 154 of the 156 references it cites were found in a registry or an index.
Abstract
Systemic type 2 inflammation encompassing T helper 2 (TH2)-type responses is emerging as a unifying feature of both classically defined allergic diseases, such as asthma, and a range of other inflammatory diseases. Rather than reducing inflammation with broad-acting immunosuppressants or narrowly targeting downstream products of the TH2 pathway, such as immunoglobulin E (IgE), efforts to target the key proximal type 2 cytokines - interleukin-4 (IL-4), IL-5 and IL-13 - represent a promising strategy to achieve therapeutic benefit across multiple diseases. After several initial disappointing clinical results with therapies targeting IL-4, IL-5 or IL-13 in asthma, applying a personalized approach achieved therapeutic benefit in an asthma subtype exhibiting an 'allergic' phenotype. More recently, efficacy was extended into a broad population of people with asthma. This argues that the Type 2 inflammation is broadly relevant across the severe asthma population if the key upstream drivers are properly blocked. Moreover, the simultaneous inhibition of IL-4 and IL-13 has shown significant clinical activity in diseases that are often co-morbid with asthma - atopic dermatitis and chronic sinusitis with nasal polyps - supporting the hypothesis that targeting a central 'driver pathway' could benefit multiple allergic diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lebrikizumab does not affect the binding of IL-13 to the IL-13Rα2 receptor chain, the biological role of which remains unclear81.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [81]
Citations
Cites
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
PAUWELS, R. A. (1996) · Arerugī/Arerugi · doi:10.15036/arerugi.45.792 · Cited by 9,994
Williams, H. C., Leung, D. Y. M., Thestrup‐Pedersen, K., & David, T. J. (2000) · Cited by 4,599
Asher, M. I., Montefort, S., Björkstén, B., Lai, C. K., Strachan, D. P., Weiland, S. K., & Williams, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69283-0 · Cited by 4,223
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617
Development and validation of a questionnaire to measure asthma control
Juniper, E. F., O′byrne, P. M., Guyatt, G. H., Ferrie, P. J., & King, D. R. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14d29.x · Cited by 2,473
Fokkens, W. J., Lund, V. J., Mullol, J., Bachert, C., Alobid, I., Baroody, F., Cohen, N., Cervin, A., Douglas, R., Gevaert, P., et al. (2012) · Rhinology journal · doi:10.4193/rhino12.000 · Cited by 2,387
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Ortega, H. G., Liu, M. C., Pavord, I. D., Brusselle, G. G., FitzGerald, J. M., Chetta, A., Humbert, M., Katz, L. E., Keene, O. N., Yancey, S. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403290 · Cited by 2,322
Severity Scoring of Atopic Dermatitis: The SCORAD Index
(2009) · Dermatology · doi:10.1159/000247298 · Cited by 2,273
Pavord, I. D., Korn, S., Howarth, P., Bleecker, E. R., Buhl, R., Keene, O. N., Ortega, H., & Chanez, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60988-x · Cited by 2,221
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Castro, M., Curran-Everett, D., Fitzpatrick, A. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0896oc · Cited by 2,129
Research works printed but not linked: 5
- Pawankar, R., Canonica, G., Holgate, S. & Lockey, R. WAO White Book on Allergy 2011–2012: Executive Summary (World Allergy Organization, 2011).
- Wenzel, S. E. et al. Inhaled pitrakinra, an IL-4/IL-13 antagonist, reduced exacerbations in patients with eosinophilic asthma. Eur. Respir. J. 36 (Suppl. 54), 713s (2010).
- Wenzel, S. et al. Dupilumab improves lung function and reduces severe exacerbations in uncontrolled asthmatics with baseline eosinophil levels above and below 300 cells/μl. Am. J. Respir. Crit. Care Med. 191, A3632 (2015).
- Kaiser, J. Medical Officer's Efficacy Review, Genentech, Omalizumab BLA STN 103976/0. US Food and Drug Administration [online] , (2003).
- Groves, R., Wilbrahams, D., Fuller, R. & Longphre, M. Inhibition of IL-4 and IL-13 with an IL-4 mutein (Aeroderm) protects against flares in atopic eczema. J. Invest. Dermatol. 127 (Suppl. 1s), S54 (2007).
Cited by
Items 201–300 of 800
Shirley, M. (2025) · Drugs · doi:10.1007/s40265-025-02151-7 · Cited by 29
Paller, A. S., Wollenberg, A., Siegfried, E. C., Thaçi, D., Cork, M. J., Arkwright, P. D., Gooderham, M., Sun, X., O’Malley, J. T., Khokhar, F. A., et al. (2021) · Pediatric Drugs · doi:10.1007/s40272-021-00459-x · Cited by 31
Dodson, J. A., & Lio, P. (2022) · Current Allergy and Asthma Reports · doi:10.1007/s11882-022-01047-w · Cited by 31
Papadopoulos, N. G., Szefler, S. J., Bacharier, L. B., Maspero, J. F., Domingo, C., Fiocchi, A. G., Lee, J. K., Daizadeh, N. S., Lederer, D. J., Hardin, M. E., et al. (2023) · Allergy · doi:10.1111/all.15743 · Cited by 29
An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma
Castagnoli, R., Licari, A., Brambilla, I., Tosca, M., Ciprandi, G., & Marseglia, G. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1812388 · Cited by 25
Ikeda, M., Ohshima, N., Kawashima, M., Shiina, M., Kitani, M., & Suzukawa, M. (2021) · Internal Medicine · doi:10.2169/internalmedicine.7990-21 · Cited by 30
The pathology of type 2 inflammation-associated itch in atopic dermatitis
Moniaga, C. S., Tominaga, M., & Takamori, K. (2021) · Diagnostics · doi:10.3390/diagnostics11112090 · Cited by 28
Deng, S., Chen, Z., & Shi, Y. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01486-8 · Cited by 30
Long-term efficacy of dupilumab in asthma with or without chronic rhinosinusitis and nasal polyps
Berger, P., Menzies-Gow, A. N., Peters, A. T., Kuna, P., Rabe, K. F., Altincatal, A., Soler, X., Pandit‐Abid, N., Siddiqui, S. S., Jacob-Nara, J. A., et al. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.11.006 · Cited by 31
Chronic systemic inflammation originating from epithelial tissues
Uluçkan, Ö., & Wagner, E. (2017) · The FEBS Journal · doi:10.1111/febs.13904 · Cited by 24
Uses of biologics in allergic diseases
Saco, T. V., Pepper, A. N., & Casale, T. B. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2018.02.029 · Cited by 30
Application of JAK inhibitors in paradoxical reaction through immune-related dermatoses
Zhang, Y., & Jiang, G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1341632 · Cited by 37
Type 2 Inflammation and Its Role in Dermatologic Diseases
Chovatiya, R., Hawkes, J. E., DiRuggiero, D., Pansch, L. A., Simcox, E., & Gonzalez, T. (2025) · International Journal of Dermatology · doi:10.1111/ijd.17707 · Cited by 30
Use of biologics in severe food allergies
Fiocchi, A. G., Pecora, V., Valluzzi, R. L., Fierro, V., & Mennini, M. (2017) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000357 · Cited by 28
Immunomodulating Agents as Antipruritics
Erickson, S. P., Nahmias, Z. P., Rosman, I. S., & Kim, B. (2018) · Dermatologic Clinics · doi:10.1016/j.det.2018.02.014 · Cited by 29
Role of CD4+ T Cells in Allergic Airway Diseases: Learning from Murine Models
Miura, K., Inoue, K., Ogura, A., & Kaminuma, O. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207480 · Cited by 29
Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors
Matucci, A., Vivarelli, E., Nencini, F., Maggi, E., & Vultaggio, A. (2021) · Biomedicines · doi:10.3390/biomedicines9101497 · Cited by 29
Cather, J. C., Young, M. S., DiRuggiero, D., Tofte, S. J., Williams, L., & Gonzalez, T. (2022) · Dermatology and Therapy · doi:10.1007/s13555-022-00778-y · Cited by 30
Real‐World Adverse Events After Type 2 Biologic use in Chronic Rhinosinusitis with Nasal Polyps
Dorling, M., Hernaiz‐Leonardo, J. C., Pascual, A., Janjua, A. S., Thamboo, A. V., & Javer, A. R. (2024) · The Laryngoscope · doi:10.1002/lary.31305 · Cited by 27
Matisz, C. E., Faz-López, B., Thomson, E. A., Rajabi, A. A., Lopes, F., Terrazas, L. I., Wang, A. Y., Sharkey, K. A., & McKay, D. M. (2017) · Scientific Reports · doi:10.1038/srep40631 · Cited by 27
Gayvert, K. M., Desrosiers, M. Y., Laidlaw, T. M., Mannent, L., Patel, K., Horowitz, J. E., Amin, N., Jagerschmidt, A., Hamilton, J. D., Lim, W. K., et al. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.05.030 · Cited by 29
Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis
Li, M., Wang, J., Liu, Q., Liu, Y., Mi, W., Li, W., & Li, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1541776 · Cited by 37
Ribosomal protein S3 gene silencing protects against experimental allergic asthma
Dong, J., Liao, W., Peh, H. Y., Chan, T. K., Tan, W. S. D., Li, L., Yong, A., & Wong, W. S. F. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13717 · Cited by 30
Shi, X., Chai, X., Yang, Y., Cheng, Q., Jiao, Y., Chen, H., Huang, J., Yang, C., & Liu, J. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa767 · Cited by 27
Sophoricoside from Styphnolobium japonicum improves experimental atopic dermatitis in mice
Kim, B.-H., & Lee, S. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153463 · Cited by 26
Guo, Z., Tong, C., Jackow, J., Doucet, Y., Abaci, H. E., Zeng, W., Hansen, C. S., Hayashi, R., DeLorenzo, D., Rami, A., et al. (2021) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10247 · Cited by 26
The New Era of Biologics in Atopic Dermatitis: A Review
Schneider, S., Li, L., & Zink, A. (2021) · Dermatology Practical & Conceptual · doi:10.5826/dpc.1104a144 · Cited by 28
Secondary immunodeficiencies and infectious considerations of biologic immunomodulatory therapies
Cannon, L. A., Pan, A., Kovalick, L. K., Sarkissian, A., & Wu, E. Y. (2023) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2023.02.010 · Cited by 26
Paller, A. S., Pinter, A., Lee, L. W., Aschoff, R., Zdybski, J., Schnopp, C., Praestgaard, A. H., Bansal, A., Shumel, B. S., Prescilla, R. P., et al. (2024) · Advances in Therapy · doi:10.1007/s12325-023-02753-1 · Cited by 33
Dupilumab in the Treatment of Asthma
Grey, A., & Katelaris, C. H. (2019) · Immunotherapy · doi:10.2217/imt-2019-0008 · Cited by 26
Maura, D., Elmekki, N. M., & Goddard, C. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-93299-1 · Cited by 26
Multidisciplinary management in type 2 inflammatory disease
Senna, G., Micheletto, C., PIACENTINI, G. L., Schiappoli, M., Girolomoni, G., Sala, G., Allievi, E., & Stassaldi, A. (2022) · Multidisciplinary Respiratory Medicine · doi:10.4081/mrm.2022.813 · Cited by 25
Zeng, Z.-W., Huang, J.-Q., Chen, Y., Xiao, Y., Zhu, W., & Zhang, D. (2022) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-022-3579-7 · Cited by 26
Gómez, L. D. P., Khan, A. H., Peters, A. T., Bachert, C., Wagenmann, M., Heffler, E. M., Hopkins, B. C., Hellings, P. W., Zhang, M., Xing, J., et al. (2022) · American Journal of Rhinology and Allergy · doi:10.1177/19458924221112211 · Cited by 26
Feng, S., Song, G., Liu, L., Liu, W., Liang, G., & Song, Z. (2022) · The Journal of Dermatology · doi:10.1111/1346-8138.16582 · Cited by 26
Busse, W. W., Pavord, I. D., Siddiqui, S. S., Khan, A. H., Praestgaard, A. H., Nash, S., Jacob-Nara, J. A., Rowe, P. J., & Deniz, Y. M. (2023) · Journal of Asthma and Allergy · doi:10.2147/jaa.s391896 · Cited by 25
How to Understand Personalized Medicine in Atopic Dermatitis Nowadays?
Mesjasz, A., Kołkowski, K., Wollenberg, A., & Trzeciak, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087557 · Cited by 28
IL-4 Haploinsufficiency Specifically Impairs IgE Responses against Allergens in Mice
Robinson, M. J., Prout, M. S., Mearns, H., Kyle, R. L., Camberis, M., Forbes‐Blom, E., Paul, W. E., Allen, C. D. C., & Gros, G. S. L. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601434 · Cited by 25
Nono, J. K., Ndlovu, H., Aziz, N. A., Mpotje, T., Hlaka, L., & Brombacher, F. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005861 · Cited by 27
Tohda, Y., Nakamura, Y., Fujisawa, T., Ebisawa, M., Arima, K., Miyata, M., Takahashi, Y., Rice, M. S., Deniz, Y. M., Rowe, P., et al. (2020) · Allergology International · doi:10.1016/j.alit.2020.04.002 · Cited by 25
Self-citationSwitching biologics in chronic rhinosinusitis with nasal polyps: A multicenter Canadian experience
Dorling, M., Sarafan, M., Voizard, B., Ammar, Y. A., Hernaiz‐Leonardo, J. C., Chalmers, K., MacInnis, P., Nugent, J. P., Janjua, A. S., Javer, A. R., et al. (2024) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23466 · Cited by 24
Pala, V., Rosset, F., Mastorino, L., Sciamarrelli, N., Boskovic, S., Borriello, S., Bongiovanni, E., Crespi, O., Ribero, S., & Quaglino, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110720 · Cited by 25
IL-4 and IL-13 Promote Proliferation of Mammary Epithelial Cells through STAT6 and IRS-1
Wu, W.-J., Wang, S., Wu, C., Su, Y., Chiang, C.-Y., Lai, C.-H., Wang, T.-H., Cheng, T., Kuo, J.-Y., Hsu, T., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112008 · Cited by 24
Li, Q., Shen, Y., Guo, X., Xu, Y., Mao, Y.-H., Wu, Y., He, F., Wang, C., Chen, Y., & Yang, Y. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c00205 · Cited by 24
Specific Therapy for T2 Asthma
Bagnasco, D., Testino, E., Nicola, S., Melissari, L., Russo, M. G., Canevari, F. R., Brussino, L., & Passalacqua, G. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040593 · Cited by 24
Yang, B., Yu, H., Jia, M., Yao, W., Diao, R., Li, B., Wang, Y., Li, T., Ge, L., & Wang, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1084879 · Cited by 24
The Multiple Trajectories of the Allergic March
Vecillas, L. D. L., & Quirce, S. (2023) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0983 · Cited by 26
Shamsollahi, H. R., Jahanbin, B., Rafieian, S., & Yunesian, M. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-13559-5 · Cited by 26
Somerville, L., Borish, L., Imre, N., & Albon, D. P. (2024) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666241297877 · Cited by 23
Targeted Biologic Therapies in Severe Asthma: Mechanisms, Biomarkers, and Clinical Applications
Văruț, R. M., Dop, D., Radivojević, K., Trașcă, D.-M., Stoica, G. A., Niculescu, Ș. A., Carmen, N. E., & Singer, C. E. (2025) · Pharmaceuticals · doi:10.3390/ph18071021 · Cited by 29
Liang, W., Li, J., Bai, C., Chen, Y., Li, Y., Huang, G., & Wang, X. (2020) · BioFactors · doi:10.1002/biof.1681 · Cited by 23
Wang, L., Xian, Y., Hu, Z. J., Loo, S. K. F., Ip, S., Chan, W. Y., Lin, Z., & Wu, J. C. Y. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114021 · Cited by 23
Strober, B. E., Mallya, U. G., Yang, M., Ganguli, S., Gadkari, A. S., Wang, J. J. J., Sierka, D., Delevry, D., & Kimball, A. B. (2021) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.4778 · Cited by 25
Al-Ahmad, M., Alsaleh, S. A., Al-Reefy, H., Abduwani, J. A., Nasr, I., Abri, R. A., Alamadi, A. M. H., Fraihat, A. A., Alterki, A., Abuzakouk, M., et al. (2022) · Journal of Asthma and Allergy · doi:10.2147/jaa.s321017 · Cited by 25
Atopy in chronic urticaria: an important yet overlooked issue
Chen, Q., Yang, X., Ni, B., & Song, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1279976 · Cited by 31
Arruda, L. K., Yang, A. C., Aoki, V., Criado, R. F. J., Pires, M. C., Lupi, O., Fabrício, L. H. Z., Richman, D., & Silvi, S. (2020) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0478 · Cited by 25
Zeng, L., Liu, Y., Xing, C., Huang, Y., Sun, X., & Sun, G. (2020) · Mediators of Inflammation · doi:10.1155/2020/4346367 · Cited by 25
Werth, V. P., Murrell, D. F., Joly, P., Heck, R., Orengo, J. M., Ardeleanu, M., & Hultsch, V. (2024) · Advances in Therapy · doi:10.1007/s12325-024-02992-w · Cited by 24
Meng, J., Xiao, H., Xu, F., She, X., Liu, C., & Canonica, G. W. (2025) · Immunologic Research · doi:10.1007/s12026-025-09606-9 · Cited by 30
Campanati, A., Bianchelli, T., Gesuita, R., Foti, C., Malara, G., Micali, G., Amerio, P., Rongioletti, F., Corazza, M., Patrizi, A., et al. (2021) · Archives of Dermatological Research · doi:10.1007/s00403-021-02243-w · Cited by 26
Calzavara‐Pinton, P., on behalf of RADAR Group, Fortina, A. B., Bonamonte, D., Marseglia, G. L., del Giudice, M. M., Musarra, A., Nettis, E., Neri, I., Patruno, C., et al. (2021) · Italian Journal of Dermatology and Venereology · doi:10.23736/s2784-8671.20.06654-7 · Cited by 24
Aldajani, A., Alroqi, A. S., Alromaih, S., Aloulah, M., & Alsaleh, S. A. (2022) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2022.103615 · Cited by 25
Kazemi, S., Murphrey, M. B., & Hawkes, J. E. (2022) · JAAD Case Reports · doi:10.1016/j.jdcr.2022.10.019 · Cited by 22
Dupilumab in the treatment of genodermatosis: A systematic review
Wu, P., Dai, Y., Li, C., Chen, C., Chang, Y.-T., & Ma, S. (2023) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14924 · Cited by 23
Lin, T., Wang, C.-Y., Wang, F., Kang, E. Y., & Hwang, Y. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041031 · Cited by 24
A Review of Dupilumab in the Treatment of Atopic Dermatitis in Infants and Children
Wang, M., Gao, X., & Zhang, L. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s457761 · Cited by 25
Т2-high and T2-low bronchial asthma, endotype characteristics and biomarkers
Nenasheva, N. M. (2019) · PULMONOLOGIYA · doi:10.18093/0869-0189-2019-29-2-216-228 · Cited by 24
Medical therapy, refractory chronic rhinosinusitis, and productivity costs
Smith, K. A., & Rudmik, L. R. (2016) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000329 · Cited by 25
Advances in Atopic Dermatitis Treatment: From Pathogenesis to Natural Product‐Based Therapies
Fan, X., Liu, Z., Yang, W., Zhang, H., Zhong, H., Pang, Y., Ye, X., Wu, C., & Li, L. (2025) · Phytotherapy Research · doi:10.1002/ptr.70056 · Cited by 22
Biologics as novel therapeutics for the treatment of allergy: Challenges and opportunities
Atanasio, A., Orengo, J. M., Sleeman, M. A., & Stahl, N. (2022) · Frontiers in Allergy · doi:10.3389/falgy.2022.1019255 · Cited by 21
Self-citationPaller, A. S., Silverberg, J. I., Cork, M. J., Guttman‐Yassky, E., Lockshin, B., Irvine, A. D., Kim, M. B., Kabashima, K., Chen, Z., Lü, Y., et al. (2023) · JAMA Dermatology · doi:10.1001/jamadermatol.2022.6192 · Cited by 26
Merola, J. F., Chiou, A. S., During, E., Costanzo, A., Foley, P. A., AlFalasi, A. A., Gogate, S. U., Pinter, A., Dodiuk‐Gad, R. P., Simon, D., et al. (2023) · British Journal of Dermatology · doi:10.1093/bjd/ljad284 · Cited by 28
Zhu, F., Qin, R., Ma, S., Zhou, Z., Tan, C., Yang, H., Zhang, P., Xu, Y., Luo, Y., Chen, J., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-90226-6 · Cited by 25
Monoclonal Antibodies and Airway Diseases
Lyly, A., Laulajainen‐Hongisto, A., Gevaert, P., Kauppi, P., & Toppila-Salmi, S. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249477 · Cited by 22
Baricitinib for the treatment of atopic dermatitis
Melo, A., Carrascosa, J. M., & Torres, T. R. (2021) · Journal of Dermatological Treatment · doi:10.1080/09546634.2021.1967268 · Cited by 22
Ameer, O. Z., Mansour, G. K., Al-Amoudi, R. S., & Abu‐Owaimer, F. M. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1631321 · Cited by 23
Asrat, S., Lim, W., Srivatsan, S., Harel, S., Gayvert, K., Birchard, D., Wipperman, M., Singh, D., Hooper, A., Scott, G., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adu3759 · Cited by 17
Barnhoorn, M. C., Jong, A. E. V. D. M., Schrama, E., Plug, L. G., Verspaget, H. W., Fibbe, W. E., van Pel, M., Hawinkels, L. J. A. C., & Schepers, K. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac054 · Cited by 23
Altieri, A., Piyadasa, H., Hemshekhar, M., Osawa, N., Recksiedler, B., Spicer, V., Hiemstra, P. S., Halayko, A. J., & Mookherjee, N. (2022) · Journal of Inflammation · doi:10.1186/s12950-022-00323-w · Cited by 24
Brusselle, G., Quirce, S., Papi, A. A., Kuna, P., Chipps, B. E., Hanania, N. A., Blaiss, M. S., Msihid, J., Jacob-Nara, J. A., Deniz, Y. M., et al. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.11.044 · Cited by 23
Atopic Dermatitis Across Shades of Skin
Quan, V. L., Erickson, T. R., Daftary, K., & Chovatiya, R. (2023) · American Journal of Clinical Dermatology · doi:10.1007/s40257-023-00797-1 · Cited by 21
Kushima, Y., Shimizu, Y., Hoshi, H., Arai, R., Ikeda, N., Nakamura, Y., Masawa, M., Okutomi, H., Yazawa, N., Chibana, K., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175721 · Cited by 24
Type 2 severe asthma: pathophysiology and treatment with biologics
Pelaia, C., Melhorn, J., Hinks, T., Couillard, S., Vatrella, A., Pelaia, G., & Pavord, I. (2024) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2024.2380072 · Cited by 18
A case report of uveitis secondary to dupilumab treatment for atopic dermatitis
Ayasse, M. T., Lockshin, B., Do, B. K., Kaiser, R., & Silverberg, J. I. (2020) · JAAD Case Reports · doi:10.1016/j.jdcr.2020.11.012 · Cited by 20
Baidya, A., & Mabalirajan, U. (2025) · doi:10.37349/eaa.2025.100973 · Cited by 25
Matschiner, G., Fitzgerald, M. F., Moebius, U., Hohlbaum, A. M., Gille, H., Jensen, K. H., Kirchfeld, K., Rattenstetter, B., Laforge, A., Aiba, R. S. B., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.12.815 · Cited by 19
Yu, N., Cui, H., Jin, S., Liu, P., Fang, Y., Sun, F., Cao, Y., Yuan, B., Xie, Y., Duan, W., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03049-z · Cited by 21
Groh, M., Fenwarth, L., Labro, M., Boudry, A., Fournier, É., Wémeau, M., Marceau‐Renaut, A., Oliveira, R. D. D., Abraham, J., Barry, M., et al. (2024) · American Journal of Hematology · doi:10.1002/ajh.27306 · Cited by 19
Luo, X., Wang, Y., Mao, Y., Xu, X., Gu, W., Li, W., Mao, C., Zheng, T., & Dong, L. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s476151 · Cited by 19
García‐Melendo, C., Cubiró, X., & Puig, L. (2021) · Actas Dermo-Sifiliográficas · doi:10.1016/j.adengl.2021.05.008 · Cited by 27
Simpson, E. L., Paller, A. S., Siegfried, E. C., Thaçi, D., Wollenberg, A., Cork, M. J., Marcoux, D., Huang, R., Chen, Z., Rossi, A. B., et al. (2021) · Europe PMC (PubMed Central) · doi:10.1007/s13555-021-00568-y · Cited by 22
Feng, S., Liu, W., Deng, S., Song, G., Zhou, J., Zheng, Z., & Song, Z. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.843230 · Cited by 22
Kim, H.-O. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01421-2 · Cited by 20
Paller, A. S., Siegfried, E. C., Cork, M. J., Wollenberg, A., Arkwright, P. D., González, M. E., Lockshin, B., Chen, Z., Bansal, A., Levit, N. A., et al. (2022) · Pediatric Drugs · doi:10.1007/s40272-022-00553-8 · Cited by 22
Paller, A. S., Mina‐Osorio, P., Vekeman, F., Boklage, S., Mallya, U. G., Ganguli, S., Kaur, M., Robitaille, M.-N., & Siegfried, E. C. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.10.038 · Cited by 20
Langley, R. G., Gherardi, G., Coleman, A., Ardeleanu, M., Rodríguez-Marco, A., Levy, S., Bansal, A., Chen, Z., Rossi, A. B., Shumel, B., et al. (2025) · American Journal of Clinical Dermatology · doi:10.1007/s40257-025-00952-w · Cited by 18
Effect of dupilumab on small airways measured by airway oscillometry in VESTIGE
Washko, G. R., Lipworth, B. J., Saralaya, D., Zhang, M., Rowe, P. J., Deniz, Y. M., Gómez, L. D. P., Sacks, H. J., & Jacob-Nara, J. A. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.06.037 · Cited by 20
A translational view of airway epithelial dysfunction in COPD
Brightling, C. E., Bafadhel, M., Han, M. K., Papon, J., Rabe, K. F., Rogliani, P., & Singh, D. (2025) · European Respiratory Review · doi:10.1183/16000617.0110-2025 · Cited by 24
Advances in co-pathogenesis of the united airway diseases
Xu, X., Yin, J., Yang, Y., Liu, H., Yu, J., Luo, X., Zhang, Y., & Song, X. (2024) · Respiratory Medicine · doi:10.1016/j.rmed.2024.107580 · Cited by 18
Özdemіr, E., & Öksüz, L. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-04134-w · Cited by 20
Metadata
- Authors
- Gandhi, N. A., Bennett, B. L., Graham, N. M. H., Pirozzi, G., Stahl, N., & Yancopoulos, G. D.
- Affiliations
- Regeneron (United States) (US)
- Sanofi (United States) (US)
- Corresponding author
- Gandhi, Namita A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-10-16
- Volume
- 15
- Issue
- 1
- Pages
- 35-50
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2200308911
- Cited by
- 766
- References
- 156
- Citations by year
- 2026: 70 · 2025: 104 · 2024: 113 · 2023: 77 · 2022: 106 · 2021: 99 · 2020: 63 · 2019: 43 · 2018: 33 · 2017: 38 · 2016: 18
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Regeneron Pharmaceuticals
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Keywords
- type 2 inflammation, IL-4, IL-5, IL-13, asthma, atopic dermatitis, Th2 cells, allergic diseases, IL-4 receptor alpha inhibition, IL-13 inhibition, IL-5 inhibition, personalized asthma therapy, drug candidates
- MeSH terms
- Antibodies, Monoclonal, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Interleukin-4, Interleukin-5, Models, Immunological, Interleukin-13, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.